This collection of articles, letters, and news releases will define AAPLOG’s positons and actions as the Mifeprex issue has evolved.
Analysis of Severe Adverse Events Related to the Use of Mifepristone as an Abortifacient by Harrison and Gary
Mifeprex use is increasing, as are the adverse events reported. To see the 2011 FDA Adverse Events Report, go to…
Politicized Science: The Manipulated Approval of RU-486 and Its Dangers to Women’s Health
“Since the Food and Drug Administration (“FDA”) approved the abortion pill RU-486 on September 28, 2000, an estimated 600,000 American RU-486 abor…
AAPLOG Statement on Current Practice Mifeprex: The Degradation of a Standard of Care
(This article was originally written in 2004 but updated in 2008) In April, 2002 the FDA issued a report on Mifeprex (RU 486) associated mishaps. M…
“Dangerous Medicine”, New York Times OP-ED Article by Donna Harrison, M.D.
“The Food and Drug Administration’s announcement on Monday that it will strengthen the warning label for the drug RU-486, known by the brand name Mife…
Legislation will Suspend FDA’s Approval of RU-486; Review FDA’s Approval Process for Drug
(WASHINGTON, D.C.) – U.S. Representatives Jim DeMint (R-S.C.), Roscoe Bartlett (R-MD) and Senator Sam Brownback (R-KS) today introduced “Holly’s Law” …
California Senator Boxer opposed FDA restrictions on abortion drug suspected in woman’s death
Holland, Michigan—On September 17, 2003 Holly Patterson, an 18 year old California woman, died within days of taking Mifeprex (RU-486 or mifepriston…
Response filed with FDA to opposition comments of the Population Council and Danco Laboratories regarding the Mifeprex Citizen Petition
Holland, Michigan—Today the American Association of Pro-Life Obstetricians and Gynecologists (AAPLOG), together with the Christian Medical Associati…
AAPLOG Files Citizen Petition on Mifepristone (Mifeprex) with FDA
AAPLOG Files Citizen Petition on Mifepristone (Mifeprex) with FDA Holland, Michigan—The American Association of Pro-Life Obstetricians and Gynecolo…
Letter to ACOG Regarding Mifepristone (Mifeprex) Advocacy
Ralph Hale, M.D. Executive Vice President The American College of Obstetricians and Gynecologists 409 12th Street, S.W. Washington, D.C. 20090-69…
AAPLOG Statement on FDA Approval of Mifeprex (RU 486)
On September 28, 2000 the United States Food and Drug Administration (FDA) announced the approval of mifepristone, in combination with misoprostol, fo…